NX-ND03

N/A

Report date: 2025/01/26 16:38:59

Base Information

Drug NameNX-ND03
Drug Alias NameNX-ND03
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuroprotectantsantioxidantApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxoltis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAxoltis Pharma
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A